Acp-103-059
Research payments
$137,150
Through program year 2019, $137,150 in research payments was reported against Acp-103-059, across 18 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $137,150 | 18 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Valerie Arnold Memphis, TN Named on 2 payments
- Inna Yuryev-Golger Brooklyn, NY Named on 1 payment
- Haydn Thomas Prairie Village, KS Named on 1 payment
- Daniel Rutrick Watertown, MA Named on 1 payment
- Kent Smalley Edmond, OK Named on 1 payment
- Michael Thase Philadelphia, PA Named on 1 payment
- Nick Vatakis New York, NY Named on 1 payment
- Michael Downing Dallas, TX Named on 1 payment
- Linda Harper Orlando, FL Named on 1 payment
- Jeffrey Ross Northbrook, IL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.